Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Shanghai Fosun Pharmaceutical Group
Pharma
Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia
Eisia's lecanemab phase 3 had one patient death. China suspends GSK from volume-based procurement. Daiichi increases its Enhertu sales projection.
Angus Liu
Nov 4, 2022 9:00am
Henlius CEO scouts for US PD-1 partner amid Fosun unit's pivot
Aug 30, 2022 1:30am
Takeda-Denali, Daiichi Sankyo, J&J-Legend—Fierce Pharma Asia
Jan 14, 2022 9:15am
China's NRDL, Biocon-Viatris and more—Fierce Pharma Asia
Dec 10, 2021 8:45am
Biogen, Pfizer, Lilly and more win China NRDL coverage
Dec 3, 2021 10:15am
BioNTech, Takeda, AZ-Daiichi and more—Fierce Pharma Asia
May 14, 2021 4:01am
